comparemela.com

Latest Breaking News On - Farma medis - Page 1 : comparemela.com

Achiko AG: Achiko s Rapid Covid-19 Diagnostic Test AptameX Receives Product and Registration Approval from Indonesia s Ministry of Health

Achiko AG: Achiko s Rapid Covid-19 Diagnostic Test AptameX Receives Product and Registration Approval from Indonesia s Ministry of Health
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Achiko s Rapid Covid-19 Diagnostic Test AptameX(TM) Receives Product and Registration Approval from Indonesia s Ministry of Health

Achiko s Rapid Covid-19 Diagnostic Test AptameX(TM) Receives Product and Registration Approval from Indonesia s Ministry of Health
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Investegate |Achiko AG Announcements | Achiko AG: Rapid Covid-19 diagnostic test AptameX(TM)

Investegate |Achiko AG Announcements | Achiko AG: Rapid Covid-19 diagnostic test AptameX(TM)
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Achiko AG: Achiko Completes Initial Shipment of Aptamex, Its Progressive Covid-19 Diagnostic Test, To Indonesia, Delivering 77% Sensitivity at Low Viral Loads

Share: Production of first 1,000 AptameX test kits is concluded in Singapore (initial capacity to test 10,000 patients per day). AptameX delivers sensitivity of 77% (95% CI: 75.94 - 79.24) at a high industry CT score of 28.3, which is comparable to current lateral flow rapid tests. Moving to complete product registration in Indonesia and progressing to securing a CE mark in Europe with a view to approvals and sales in Q3 2021. ZURICH, GERMANY / ACCESSWIRE / May 20, 2021 / Achiko AG (SWX:ACHI, ISIN CH0522213468) completed production of the first 1,000 AptameX test kits and has commenced shipment to Indonesia. The Company also announces favourable preliminary Covid-19 diagnostic testing results at a high CT score; even at low viral loads, AptameX proves to be highly sensitive.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.